Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120954176 | 12095417 | 6 | F | 20160207 | 20160802 | 20160219 | 20160805 | EXP | AU-ABBVIE-16P-008-1561797-00 | ABBVIE | 64.05 | YR | F | Y | 0.00000 | 20160805 | MD | COUNTRY NOT SPECIFIED | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120954176 | 12095417 | 1 | PS | VIEKIRA PAK | DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | AV1 X2 IN MORNING, AV2 X 1, 2 TIMES A DAY | U | UNKNOWN | 206619 | ||||||||
| 120954176 | 12095417 | 2 | SS | VIEKIRA PAK | DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR | 1 | U | UNKNOWN | 206619 | ||||||||||
| 120954176 | 12095417 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | U | UNKNOWN | 0 | |||||||||
| 120954176 | 12095417 | 4 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | U | UNKNOWN | 0 | ||||||||||
| 120954176 | 12095417 | 5 | C | GLICLAZIDE | GLICLAZIDE | 1 | 0 | ||||||||||||
| 120954176 | 12095417 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 120954176 | 12095417 | 7 | C | METOCLOPRAMIDE HYDROCHLORIDE. | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 120954176 | 12095417 | 8 | C | PREGABALIN. | PREGABALIN | 1 | 0 | ||||||||||||
| 120954176 | 12095417 | 9 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 0 | ||||||||||||
| 120954176 | 12095417 | 10 | C | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 120954176 | 12095417 | 11 | C | PROPRANOLOL HYDROCHLORIDE. | PROPRANOLOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 120954176 | 12095417 | 12 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120954176 | 12095417 | 1 | Chronic hepatitis C |
| 120954176 | 12095417 | 2 | Hepatic cirrhosis |
| 120954176 | 12095417 | 3 | Chronic hepatitis C |
| 120954176 | 12095417 | 4 | Hepatic cirrhosis |
| 120954176 | 12095417 | 5 | Product used for unknown indication |
| 120954176 | 12095417 | 6 | Product used for unknown indication |
| 120954176 | 12095417 | 7 | Product used for unknown indication |
| 120954176 | 12095417 | 8 | Product used for unknown indication |
| 120954176 | 12095417 | 9 | Product used for unknown indication |
| 120954176 | 12095417 | 10 | Product used for unknown indication |
| 120954176 | 12095417 | 11 | Product used for unknown indication |
| 120954176 | 12095417 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120954176 | 12095417 | OT |
| 120954176 | 12095417 | HO |
| 120954176 | 12095417 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120954176 | 12095417 | Blood bilirubin increased | |
| 120954176 | 12095417 | Disease progression | |
| 120954176 | 12095417 | Dizziness | |
| 120954176 | 12095417 | Hepatic failure | |
| 120954176 | 12095417 | Jaundice | |
| 120954176 | 12095417 | Nausea | |
| 120954176 | 12095417 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120954176 | 12095417 | 1 | 20160202 | 20160209 | 0 | |
| 120954176 | 12095417 | 3 | 20160202 | 20160209 | 0 |